Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
medical development are welcome and we might actually recruit two persons with complementary expertise. Additional information may be found in the following selected references: De Strooper, B. & Karran, E
-
developing genetic risk scores as biomarkers for neurological disorders. The Rademakers lab leads cutting-edge research into risk genes and molecular mechanisms in Frontotemporal Dementia (FTD), while
-
Postdoctoral position to study species-specific mechanisms of gene regulation in human neurons. The Vanderhaeghen Lab (https://pvdhlab.org ) and the Aerts Lab (www.aertslab.org ) at VIB KULeuven are seeking creative postdoctoral scientists to study the human-specific mechanisms of gene...
-
the Simons Foundation Autism Research Initiative (SFARI). This collaborative initiative with the labs of Pierre Vanderhaeghen (VIB-KU Leuven) and Franck Polleux (Columbia University) aims to elucidate how
-
supported by a Foundation against Cancer (2025 – 2030). We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in tumor-associated macrophages (TAMs) in vivo. We
-
the development of genetic autoinflammatory diseases. Using techniques in cell biology, molecular biology and biophysics you will investigate how loss of function of the RNA editing enzyme ADAR1 causes the human
-
departments; building strong relationships with translational stakeholders, including academic hospitals, universities and research organizations; developing VIB-wide supportive activities related
-
initiative investigating how human-specific features of brain development shape early behavior and neural circuit function in autism spectrum disorders (ASD). This position is a joint effort between the
-
funded by the Flemish government and works in close partnership with five Flemish universities – Ghent University, KU Leuven, University of Antwerp, Vrije Universiteit Brussel, and Hasselt University
-
Advanced Grant (2025 – 2030). We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in liver macrophages in vivo. We will apply these technologies to unravel